{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:06:45Z","timestamp":1763644005871,"version":"3.45.0"},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Colorectal cancer (CRC) is considered to be a heterogeneous disease with different molecular subtypes based on the expression status of mismatch repair (MMR) e.g. It is well known that tumours with mismatch repair deficiency (dMMR) are associated with better prognosis, as well as a more effective response to immunotherapy. In this case report, a patient is diagnosed with three new dMMR tumors in the colon 3,5 years after successful treatment with immunotherapy for metastatic CRC. Until now, retreatment with immunotherapy has not been described in the literature, and this case report describes the advantages and disadvantages from this perspective.<\/jats:p>","DOI":"10.61409\/v05250368","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:19:06Z","timestamp":1763558346000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["Metachronous colon cancer after successful treatment of mismatch repair-deficient metastatic colorectal cancer"],"prefix":"10.61409","author":[{"given":"Line","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B\u00f8dker","family":"Lauritzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Makieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malene","family":"Lundsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lykke","family":"Grubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurids \u00d8.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Le DT, Durham JN, Smith KN et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409-413. https:\/\/doi.org\/10.1126\/science.aan6733","DOI":"10.1126\/science.aan6733"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Diaz Jr LA, Shiu KK, Kim TW et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022;23(5):659-670. https:\/\/doi.org\/10.1016\/S1470-2045(22)00197-8","DOI":"10.1016\/S1470-2045(22)00197-8"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ta\u00efeb J, Bouche O, Andr\u00e9 T et al. Avelumab vs standard second-line chemotherapy in patients with metastatic colorectal cancer and microsatellite instability. JAMA Oncol. 2023;9(10):1356-1363. https:\/\/doi.org\/10.1001\/jamaoncol.2023.2761","DOI":"10.1001\/jamaoncol.2023.2761"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"G\u00f6genur I, Justesen TF, Tarpgaard LS et al. Neoadjuvant pembrolizumab in stage I-III deficient mismatch repair colon cancer. Ann Surg. 2024 Dec 18. https:\/\/doi.org\/10.1097\/SLA.0000000000006611 Online ahead of print","DOI":"10.1097\/SLA.0000000000006611"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Andr\u00e9 T, Elez E, Lenz HJ et al. Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial. Lancet. 2025;405(10476):383-395. https:\/\/doi.org\/10.1016\/S0140-6736(24)02848-4","DOI":"10.1016\/S0140-6736(24)02848-4"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:55:28Z","timestamp":1763643328000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V05250368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v05250368","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}